Microsoft today launched a number of key cancer-fighting projects it has under way, showing off its application of machine learning to solve bigger challenges than identifying dog breeds.
One such application, called Project Hanover, is seeking to make personalized, precision cancer therapy available to all cancer patients by helping oncologists sift through reams of biomedical research papers faster.
Microsoft is targeting the so-called ‘molecular tumor board’, the group that convenes to devise personal therapy to suit a patient’s specific cancer. However, oncologists are hampered by the volume of research required to assess the particulars of each cancer, limiting access to the most serious cases.
Microsoft says that the US government’s PubMed service publishes two new papers each minute, or more than one million a year.